Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 9.1.2025Reddy Holding GmbH (RDD)8929DCinacalcet Reddy 30 mg filmom obalené tablety (tbl flm 28x30 mg (blis.PVC/Aclar/Al))9.1.2025R
 9.1.2025Teva B.V. (TEV-NL-4)53193Olanzapin Actavis 5 mg (tbl oro 56x5 mg (blis.Al/Al s odlep.fóliou))8.1.2025O
 8.1.2025medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)4592EMetoject PEN 12,5 mg injekčný roztok naplnený v injekčnom pere (sol ira 1x0,25 ml/12,5 mg (pero napl. YpsoMate))9.1.2025U
 8.1.2025medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)8895AMetoject PEN 12,5 mg injekčný roztok naplnený v injekčnom pere (sol ira 1x0,25 ml/12,5 mg (pero napl. BD))31.1.2025Z
 8.1.2025Noridem Enterprises Ltd. (NID)5167DParacetamol Noridem 10 mg/ml infúzny roztok (sol inf 10x100 ml/1000 mg (fľ.PP))8.1.2025O
 8.1.2025B.Braun Melsungen AG (BME)34254Glukóza B. Braun 5 % infúzny roztok (sol inf 10x500 ml (fľ.LDPE))8.1.2025R
 8.1.2025B.Braun Melsungen AG (BME)1343CNutriflex Omega special 56/144 (emu inf 5x625 ml (vak infúzny viackomorový))8.1.2025O
 8.1.2025Noridem Enterprises Ltd. (NID)0478DCefazolín Noridem 1 g prášok na injekčný/infúzny roztok (plo ijf 10x1 g (liek.inj.skl.))8.1.2025U
 8.1.2025Olikla s.r.o. (OLK)2753EOlopatadine Olikla 1 mg/ml očné roztokové kvapky (int opo 1x5 ml (fľ.LDPE))8.1.2025U
 8.1.2025Olikla s.r.o. (OLK)4304EBrimonidin/timolol Olikla 2 mg/ml + 5 mg/ml očné roztokové kvapky (int opo 1x5 ml (fľ.LDPE))8.1.2025U
 8.1.2025Olikla s.r.o. (OLK)6456EVancomycin Olikla 1000 mg prášok na koncentrát na infúzny roztok (plc ifc 10x1000 mg (liek.inj.skl.))8.1.2025U
 7.1.2025CROMA-PHARMA GmbH (COM)3367ELetybo 50 jednotiek prášok na injekčný roztok (plv ino 1x5 ml (liek.inj.skl.))17.12.2024U
 7.1.2025B.Braun Melsungen AG (BME)5006BAqua pro injectione Braun (lif par 20x100 ml (fľ.LDPE))7.1.2025R
 7.1.2025Takeda Pharmaceuticals International AG Ireland Branch (TAK-IE-1)36386Fosrenol 750 mg žuvacie tablety (tbl mnd 90(6x15)x750 mg (fľ.HDPE-multi bal.))7.1.2025O
 7.1.2025Viatris Limited (VIM)2266EVixargio 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/PVDC/Al))7.1.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)